Quick Takeaways
- Bellevue Group AG filed SCHEDULE 13G for MacroGenics, Inc. Common Stock (MGNX).
- Disclosed ownership: 16%.
- Date of event: 01 Jun 2025.
Bellevue Group AG - 01 Jun 2025 SCHEDULE 13G Report for MacroGenics, Inc. Common Stock (MGNX)
- Filing Manager
- Bellevue Group AG
- Reporting Manager
- Bellevue Group AG
- Security
- MacroGenics, Inc. Common Stock
- Symbol
- MGNX
- Shares outstanding
- 63,248,172 shares
- Disclosed Ownership
- 9,929,963 shares
- Ownership
- 16%
- Form type
- SCHEDULE 13G
- Filing time
- 07 Jul 2025, 19:20:25 UTC
- Date of event
- 01 Jun 2025
- Next filing
- 06 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Bellevue Group AG disclosed 16% ownership in MacroGenics, Inc. Common Stock (MGNX) on 01 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Jul 2025, 19:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bellevue Group AG | 16% | 9,929,963 | 0 | 9,929,963 | /s/ Stefano Montalbano | Stefano Montalbano/ Chief Financial Officer | |
| Bellevue Asset Management AG | 16% | 9,929,963 | 0 | 9,929,963 | /s/ Christoph Eisenring | Christoph Eisenring/ Head Legal & Compliance |